Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer-Reference-Cited by-同舟云学术

Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer

Published:2019-01 Issue: Volume:110 Page:163-168
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Kim Eric^ORCID,Mema Eralda,Axelrod Deborah,Sigmund Eric,Kim Sungheon Gene,Babb James,Melsaether Amy N

Funder

National Institute of Health

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference33 articles.

1. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer;Lee;J. Am. Coll. Radiol.,2010

2. ACR BI-RADS® mammography;Sickles,2013

3. Risk for breast cancer development determined by mammographic parenchymal pattern;Wolfe;Cancer,1976

4. Breast patterns as an index of risk for developing breast cancer;Wolfe;AJR Am. J. Roentgenol.,1976

5. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study;Wolfe;AJR Am. J. Roentgenol.,1987

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of background parenchymal enhancement on breast MRI with breast cancer;Clinical Radiology;2023-09

2. Background parenchymal enhancement and uptake as breast cancer imaging biomarkers: A state-of-the-art review;Clinical Imaging;2022-03

3. Evaluation of primary breast cancers using dedicated breast PET and whole-body PET;Scientific Reports;2020-12

4. Metabolic changes in breast cancer on dual-time-point 18F-FDG PET/CT imaging according to primary tumor uptake and background parenchymal enhancement;Annals of Nuclear Medicine;2020-09-24